make it quite clear that considerable difference of opinion exists between independent observers regarding the nature of a lump in the breast when the diagnosis is based on clinical examination and mammography. In their experience when over 1000 women were screened for the disease by these methods an accurate assessment of the disease was made in only 18 % of those who had breast cancer.
Despite the difficulty in discriminating between benign and malignant disease at the screening clinic, the authors felt the problem would be resolved pnce the patient was referred to a hospital for an opinion. In fact, referral from a screening clinic to a hospital for further diagnosis and management compounds rather than resolves the problem. The patient is subjected to the same investigation as she has already had at the screening clinic, namely palpation and mammography. The same limitations of the techniques would seem to apply, as is reflected in the large numbers of biopsies in the series -119 in all, of which only 17 (1 in 7) were malignant.
Any other diagnostic tests which can contribute to diagnosis before surgery would be advantageous to the patient and clinician alike. I would like to examine here the contribution fine needle aspiration cytology of breast lesions can make to the initial assessment and diagnosis of the patient who presents with a lump in her breast. For the last two years, every woman attending the combined breast clinic at St Mary's Hospital with a discrete palpable breast lump has been subjected to fine needle aspiration. This report, which is based on our own experience and the observations of others, is a practical evaluation of the test in terms of the patient's comfort and safety, and the reliability and accuracy of diagnosis.
Foremost among any assessment of the usefulness of the aspiration technique must be how far it is acceptable to the patient. In general we have found that it is readily accepted. It involves minimal discomfort and no bruising;. a local anmsthetic is not required. The technique we employ is illustrated in Fig 1 and has been described in a previous report (Coleman et al. 1975) .
The safety of the technique is of equal importance, and this has been investigated most thoroughly by Engzell et al. (1971) following reports of dissemination of tumour along the track of the needle. Recurrence of tumour along the path of the needle after aspiration of papillary carcinoma of the thyroid with a Silverman needle was reported (Crile & Hazard 1951) and spread of tumour cells after transperineal aspiration ofthe prostate with a large bore needle has also been described (Clarke et al. 1953) .
Engzell & Zajicek investigated the problem using, as their model, metastatic carcinoma of the popliteal nodes in rabbits. They cannulated lymphatics and veins draining the nodes but did not find tumour cells in efferent lymph or blood as a result of manipulation or fine needle aspiration of the malignant nodes. Moreover, in a clinical study of over 1200 patients, with a variety of malignant tumours, who had been subject to fine needle aspiration, evidence of dissemination of tumour was not found five years after aspiration. They concluded that while dissemination of tumour may be a consequence of aspiration with a large bore needle, it is very unlikely to result from fine needle aspiration. 
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The diagnostic accuracy and reliability of the test can be examined from several different viewpoints. For example, can the cytologist discriminate consistently between benign and malignant cells and does clinical bias affect his judgment? Webb (1975) investigated this aspect and showed that the overall diagnostic accuracy of the cytologist improved only marginally when he had clinical information of the nature of the case.
Another aspect of the reliability of the test is the frequency of obtaining aspirates unsuitable for cytological examination. When comparing the percentages of unsatisfactory smears from different centres the wide variation in the cytological processing of the specimen should be borne in mind. For example, Furnival and his colleagues (1975) recently admitted to obtaining 250% unsatisfactory smears: we feel such a figure may be due to the smear-making technique, where a small amount of cellular material from a solid lesion is expelled from the fine bore needle onto a slide, smeared and fixed, causing air drying which distorts the cells. At St Mary's l4ospital a millipore technique is used which ensures that all available cellular material is preserved and processed, with an unsatisfactory rate of only 4%. The cell morphology is well preserved using this technique (Fig 2) and correlates with the histopathological appearances of the tumours. We would emphasize that our low level of unsatisfactory smears is not achieved at the expense of diagnostic accuracy, which compares very well with other centres. To examine that accuracy, in terms of the sensitivity and specificity of the test, I have compared the results at St Mary's Hospital with the results of two other centres. which carry out needle aspirations (Tables I and 2) .
Our results are fairly consistent: we have a 900% accuracy in detecting malignant lesions with false negative reports in 10% of the cases.
Unfortunately, this false negative rate of 10% fails to improve with experience, representing as it does an error of sampling inevitable in the technique, rather than a diagnostic error on the ptrt of the cytologist. This is borne out by our own experience that repeat sampling of a tumour increases the accuracy of the cytodiagnosis.
Further to this point, we see that a very low false negative rate of 0.1 % can be achieved with experience and 980 correct diagnosis of a benign breast lesion obtained. The test, then, is acceptable and safe for the patient, convenient for the doctor and a reasonably accurate screening test. It would therefore be appropriate to examine the role it has to play in the inifial assessment of the patient presenting with a lump in the breast. This has been done at St Mary's Hospital and our initial experience of 145 cases has been reported elsewhere (Coleman et al. 1975 ). Our experience now extends to 347 patients who presented at the combined breast clinic at St Mary's Hospital, where a clinical assessment of each breast lesion was made. The lumps were first graded by the clinician into three classes: clinically benign, malignant and doubtful. Needle aspiration was then performed and the cytology was reported within 24 hours. We were interested to compare the initial clinical assessment with the cytological diagnosis of the breast lump and with the final diagnosis (Table 3) .
Of the 217 lesions thought to be benign on clinical assessment, cytology accurately assessed 212 as benign and 4 as malignantthus picking up 4 cases in which the diagnosis might have been delayed. The one false positive report was accounted for by a very proliferative smear from a fibroadenoma, an error probably due to lack of cytological experience. Zajicek has shown that with experience, false positive reports can be largely eliminated.
If we consider the 85 lesions assessed clinically and thought to be malignant the accuracy of cytology was less satisfactory. Only 5 lesions were correctly diagnosed as benign, while the false negative reports were undoubtedly due to errors of samplingall were scirrhous carcinomas. Nevertheless, while stressing that a clinical diagnosis of malignancy must always override a cytological opinion we can, by adopting a combined clinical and cytological approach, provide a firmer basis for the diagnosis of benign breast disease.
It is, however, in assessing the doubtful cases that we hope' cytology can make the most valuable contribution. Indeed, in 17 of the lesions reported as malignant, we were correct in all but one, which was found later to be a cylindroma. We reported 23 of the cases correctly as benign, but the 5 erroneous false negative reports were again sampling errors. Of the women with clinically doubtful lesions, 19 had mammograms, and in 14 patients the cytological and mammographic findings were concordant and consistent with the final diagnosis. These results suggest that our combined cytologic and mammographic investigations of doubtful lumps could provide a reliable assessment of the lesion, when the results are in agreement. This aspect of the application of cytology should be investigated further, for where both tests are carried out, their concordance could provide a diagnosis with a very high degree of accuracy.
In summary then, this safe, convenient and accurate test would seem to warrant more general use, especially to confirm lesions diagnosed clinically and radiologically as benign, while its role in the diagnosis of lesions of doubtful malignancy needs to be explored further.
It has been found that this test can be of value to the surgeon in his initial assessment of the patient prior to surgery and, if considered together with clinical and radiological findings, of considerable assistance in the selection of cases for frozen section or excision biopsy. The examination of urine for malignant cells in asymptomatic individuals is only a worthwhile procedure in a selected group known to be at risk. Several reports have demonstrated the futility of screening the general population for bladder cancer. The largest group examined was 6500 patients over 40 years of age in a general hospital with symptoms other than those suggesting disease of the genitourinary tract (Macfarlane 1963). Not one case of cancer of the bladder was revealed.
